Add to ORKGThe management of systemic fungal infections can be divided into four main strategies: prophylaxis, early empirical use, pre-emptive therapy and target therapy. This article addresses the use of itraconazole for fungal infections in patients with haematological malignancies or receiving bone marrow transplantation (BMT). Itraconazole is now available in both oral and intravenous formulations, with a broad spectrum of activity including Aspergillus, and Candida albicans and non-albicans species. Plenty of controlled clinical trials have confirmed that prophylaxis with itraconazole is effective in reducing rates of systemic fungal infections. In empirical use, large randomized studies have supported the efficacy of itraconazole, while in the ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
Effective prevention, or treatment, of invasive fungal infection in the neutropenic patient has hith...
ABSTRACTResults from randomised, controlled trials and routine clinical experience indicate that itr...
The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its ...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
The pharmacokinetics, efficacy, and safety of intravenous (iv) itraconazole (2 days at 400 mg/day, 1...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
Effective prevention, or treatment, of invasive fungal infection in the neutropenic patient has hith...
ABSTRACTResults from randomised, controlled trials and routine clinical experience indicate that itr...
The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its ...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological m...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
The pharmacokinetics, efficacy, and safety of intravenous (iv) itraconazole (2 days at 400 mg/day, 1...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, ...
Effective prevention, or treatment, of invasive fungal infection in the neutropenic patient has hith...